[{"Assets_0_Q3_USD":"1212000000.0","CIK":"899923","CommonStockSharesIssued_0_Q3_shares":"80900000.0","CommonStockSharesOutstanding_0_Q3_shares":"80900000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.43","EarningsPerShareBasic_3_Q3_USD":"-0.87","EarningsPerShareDiluted_1_Q3_USD":"-0.43","EarningsPerShareDiluted_3_Q3_USD":"-0.87","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q3_USD":"0.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-98600000.0","NetIncomeLoss_1_Q3_USD":"-35100000.0","NetIncomeLoss_3_Q3_USD":"-69700000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q3_USD":"-35100000.0","ProfitLoss_3_Q3_USD":"-69700000.0","RevenuesConverted_1_Q3_USD":"156400000.0","RevenuesConverted_3_Q3_USD":"500600000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"916600000.0","StockholdersEquity_0_Q3_USD":"916600000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"80700000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"80400000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"80700000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"80400000.0","filed":"20221102","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"MYRIAD GENETICS INC","period":"20220930","qtrs":"0","uom":"USD"}]